Clinical pathways are likely to serve as a valuable tool in the transition to a value-based system of care and may also serve as potential leverage in policy regarding delivery reform, according to Robin Zon, MD.
Survivors of chronic cancer are often not receiving optimal survivorship care plans and follow-up treatment.
Clinical trial participation for patients with cancer often result in measurable benefits, including lowered costs and extended survival.
The Centers for Medicare and Medicaid Services is working toward addressing challenges associated with an episode-based payment model as part of the Oncology Care Model.
A report from the American Cancer Society Cancer Action Network estimated the total costs to patients associated with cancer diagnoses and treatment, based on their type of insurance.